Insecticides (India) Limited — PPTs, 10-02-2025: Investor Presentation

Financial Highlights: In Q3 FY25, Insecticides (India) Limited reported a marginal revenue decrease to ₹357.7 crore, compared to ₹357.9 crore in Q3 FY24. However, the company demonstrated improved profitability with EBITDA rising by 19% to ₹30.9 crore, resulting in an EBITDA margin of 8.6% compared to 7.3% the previous year. PAT surged by 42% to ₹17.4 crore, equating to an EPS of ₹6.04, marking a significant increase from ₹4.24 in Q3 FY24. For the nine months ending December 2024, revenue stood at ₹1,641 crore, down 3% year-on-year, yet EBITDA improved by 26% to ₹192.7 crore, and PAT increased by 36% to ₹128.2 crore.

Strategic Initiatives and Growth Drivers: The company remains focused on product innovation, boasting a robust portfolio with significant R&D efforts and a strategic distribution network capable of reaching 2.5 million farmers. Their commitment to sustainable agriculture and digital transformation enhances their operational efficiency.

Investor Implications: The results reflect a positive trend in profitability, driven by effective cost management and strategic brand positioning. Investors should monitor the company’s ability to leverage its strong distribution network and R&D capabilities to adapt to market demands, ensuring potential growth in the competitive agrochemical sector.